BDSX

SEC filing BDSX Announces 2026 Annual Meeting Voting Results, Elects Directors, Approves Executive Pay and KPMG Appointment

12d ago

News Biodesix raises 2026 revenue outlook to $108M-$114M as it targets sustained adjusted EBITDA profitability

28d ago

News Biodesix outlines $106M–$112M 2026 revenue target as sales expansion drives 41% Q4 growth

95d ago

Insider trade Sale by Scott Hutton (President & CEO)

95d ago

Insider trade Sale by Robin Harper Cowie (CFO, Sec'y & Treasurer)

95d ago

Insider trade Sale by Gary Anthony Pestano (Chief Development Officer)

95d ago

Insider trade Sale by Chris Vazquez (Chief Accounting Officer)

95d ago

Insider trade Sale by Kieran O'Kane (Chief Commercial Officer)

95d ago

Insider trade Sale by Scott Hutton

104d ago

Insider trade Sale by Kieran O'Kane

104d ago

Insider trade Sale by Robin Harper Cowie

104d ago

Insider trade Sale by Gary Anthony Pestano

104d ago

Insider trade Sale by Chris Vazquez

104d ago

Insider trade Purchase by SCHULER JACK W

104d ago

Insider trade Purchase by SCHULER JACK W

104d ago

News BioTissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation with Sale of Surgical and Wound Care Business to BioStem Technologies

131d ago

News Biodesix skyrockets 43%, expects FY revenue to beat guidance

141d ago

News Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)

141d ago